Riskpilot← Back to searchSign inGet full accessARTHREX DANMARK A/S
A/SActiveCVR 33971176Islands Brygge 43, 2.Wholesale of pharmaceutical and medical goods · NACE 4646Est. 201125 employees
Revenue 2025
DKK 33M
+10% vs 2024
EBITDA margin
42.1%
+8% vs 2024
Equity ratio
70.8%
Financial strength
Net profit 2025
DKK 7,5M
+2% vs 2024
| Revenue | DKK 33M | +10% |
| EBITDA | DKK 13,9M | +8% |
| Net profit | DKK 7,5M | +2% |
| Total assets | DKK 52,7M | +12% |
| Equity | DKK 37,3M | +25% |
| Employees | 25 | — |
Legal name
ARTHREX DANMARK A/S
CVR number
33971176
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
15. oktober 2011
Share capital
DKK 501.000
Employees
25 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af et medlem af bestyrelsen eller et medlem af direktionen.
Company purpose
Selskabets formål er at drive engros- og detailsalg og køb af, markedsføring af og distribution af medicinske produkter til ortopædiske operationer, eftersalgs-service og import og eksport af sådanne produkter samt at drive enhver virksomhed, der er forenelig hermed. Desuden skal selskabet være repræsentant for indenlandske eller udenlandske virksomheder, som udøver tilsvarende aktiviteter.
Address
Islands Brygge 43, 2.
Phone
+4532315030
Email
info@arthrex.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 664 | 2.454 | 4.606 | 8.120 | 11.466 | 27.188 | 12.948 | 15.093 | 17.612 | 23.613 | 21.312 | 29.862 | 29.900 | 32.972 |
| Staff expenses | -2.104 | -4.487 | -5.719 | -7.538 | -9.845 | -9.139 | -7.898 | -10.188 | -11.354 | -13.757 | -13.119 | -15.264 | -16.997 | -18.215 |
| EBITDA | -1.439 | -2.033 | -1.113 | 582 | 1.621 | 18.049 | 5.050 | 4.905 | 6.238 | 9.811 | 8.193 | 14.598 | 12.902 | 13.876 |
| Depreciation & amort. | 138 | -687 | -1.769 | -4.040 | -6.423 | -2.695 | -1.141 | -1.863 | -4.183 | -4.128 | -4.128 | -3.809 | -3.297 | -3.770 |
| EBIT | -1.577 | -2.720 | -2.881 | -3.458 | -4.801 | 15.354 | 3.909 | 3.042 | 2.055 | 5.683 | 4.065 | 10.789 | 9.606 | 10.106 |
| Net financials | -1 | -37 | -1 | -49 | -32 | -304 | 167 | -193 | 47 | -60 | -392 | -82 | -30 | -257 |
| Profit before tax | -1.578 | -2.757 | -2.883 | -3.507 | -4.770 | 15.050 | 4.076 | 2.849 | 2.102 | 5.623 | 3.673 | 10.707 | 9.575 | 9.848 |
| Tax | -0 | -0 | -0 | -0 | -0 | 2.764 | 283 | 674 | 657 | -405 | 797 | 2.407 | 2.207 | 2.310 |
| Net profit | -1.578 | -2.757 | -2.883 | -3.507 | -4.770 | 12.286 | 3.793 | 2.175 | 1.445 | 6.028 | 2.876 | 8.300 | 7.368 | 7.539 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4.265 | 6.652 | 16.087 | 19.729 | 17.659 | 16.077 | 23.412 | 25.584 | 35.749 | 33.955 | 37.799 | 38.769 | 47.155 | 52.710 |
| Equity | -578 | -3.335 | -6.218 | -9.724 | -14.494 | -2.208 | 1.585 | 3.760 | 5.205 | 11.233 | 14.108 | 22.408 | 29.776 | 37.315 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 815 | 815 | 0 | 874 | 0 |
| Short-term debt | 4.843 | 9.987 | 22.304 | 29.453 | 32.153 | 18.286 | 21.827 | 21.824 | 30.544 | 21.907 | 22.875 | 16.361 | 16.505 | 15.395 |
| Total debt | 4.843 | 9.987 | 22.304 | 29.453 | 32.153 | 18.286 | 21.827 | 21.824 | 30.544 | 22.722 | 23.690 | 16.361 | 17.379 | 15.395 |
EBITDA margin
42.1%
This company
15.8%
Market median
+166% vs market
20122025
Equity ratio
70.8%
This company
38.2%
Market median
+85% vs market
20122025
Return on equity
20.2%
This company
18.4%
Market median
+10% vs market
20122025
Net profit margin
22.9%
This company
8.1%
Market median
+183% vs market
20122025
Asset turnover
0.63×
This company
1.12×
Market median
-44% vs market
20122025
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-15 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TF Management | Management | 2011 | — | — |
PA Management | Management | 2011 | — | — |
PA Management | Management | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2011 | — | — | |
| Chairman | 2023 | — | — | |
| Chairman | 2011 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2011 | — | — | |
| Chairman | 2011 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2011 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ARTHREX DANMARK A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Timothy Francis Egan | Management | 0 companies |
| Peter Andreas Stakemann | Management | 0 companies |
| Philip Axel Johannes Alm | Management | 0 companies |
| Johannes Maximilian Schäferhoff | Board of Directors | 0 companies |
| Torgeir Erlandsen | Chairman | 0 companies |
| Jørgen Herman Melchior | Chairman | 0 companies |
| Geert Jos Marcel Onan | Board of Directors | 0 companies |
| Lone Annette Saul Stakemann | Board of Directors | 0 companies |
| Stefan Hans Josef Krupp | Chairman | 0 companies |